Anja Zeller

Title: Anja Zeller: Innovator in Immunotherapy

Introduction

Anja Zeller is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of immunotherapy, particularly in the treatment of amyloidoses and protein aggregation disorders. With two patents to her name, her work focuses on enhancing immune responses to combat diseases such as Alzheimer's.

Latest Patents

Anja Zeller's latest patents include a method for providing patient-specific immune responses in amyloidoses and protein aggregation disorders. This innovative treatment aims to enhance or sustain an antibody response directed against pathological protein aggregates or neo-epitopes present on pathogenic forms of proteins or protein complexes. Furthermore, her patents describe therapeutic methods where ex vivo stimulated antigen-selected peripheral blood lymphocytes are regrafted into the cognate donor, offering a promising approach to treating Alzheimer's disease and other disorders involving protein misfolding or aggregation.

Career Highlights

Throughout her career, Anja Zeller has worked with esteemed institutions such as New York University and Neurimmune Holding AG. Her research has been pivotal in advancing the understanding of immune responses in relation to neurodegenerative diseases.

Collaborations

Anja has collaborated with notable colleagues, including Karsten Henco and Roger Nitsch, contributing to a rich exchange of ideas and innovations in her field.

Conclusion

Anja Zeller's work exemplifies the intersection of innovation and healthcare, showcasing her dedication to improving treatments for complex diseases. Her contributions continue to inspire advancements in immunotherapy and patient care.